Asthma Control

Respiratory
1
Pipeline Programs
2
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Regeneron
RegeneronTARRYTOWN, NY
1 program
1
Dupilumab Prefilled SyringePhase 3
AstraZeneca
AstraZenecaCAMBRIDGE, United Kingdom
1 program
AsthmaOptimiser-supported structured asthma reviewN/A1 trial
Active Trials
NCT07390669Active Not Recruiting746Est. Jul 2026

Trial Timeline

Clinical trial activity over time

2025
2026
AstraZenecaAsthmaOptimiser-supported structured asthma review

Clinical Trials (1)

Total enrollment: 746 patients across 1 trials

NCT07390669AstraZenecaAsthmaOptimiser-supported structured asthma review

OptimAIR: Towards Right Care in Asthma Through Point-of-care Phenotyping, Guideline-based Assessment and Management Optimalisation Using the AsthmaOptimiser in Primary Care

Start: May 2025Est. completion: Jul 2026746 patients
N/AActive Not Recruiting

Related Jobs in Respiratory

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 late-stage (Phase 3) programs — potential near-term approvals
2 companies competing in this space